Standardized pulmonary vein isolation workflow to enclose veins with contiguous lesions: the multicentre VISTAX trial
ConclusionsThe VISTAX trial demonstrated that a standardized PAF ablation workflow aiming for contiguous lesions leads to low rates of PAEs, high acute first-pass isolation rates, and 12-month freedom from arrhythmias approaching 80%. Further research is needed to improve the reproducibility of the outcomes across a wider range of centres.Clinical trial registration: ClinicalTrials.gov, number NCT03062046,https://clinicaltrials.gov/ct2/show/NCT03062046.
Source: Europace - Category: Cardiology Source Type: research
More News: Arrhythmia | Atrial Fibrillation | Cardiology | Clinical Trials | Electrocardiogram | Study